一种I型干扰素调节网络,用于基于肝素,膜结合和可溶性BDCA-2的人体血细胞树突细胞
Francisco Venegas-Solis1, Laura Staliunaite1, Elisa Rudolph1
1Institute for Immunology, Philipps-Universität Marburg, Biomedizinisches Forschungszentrum Marburg, Marburg 35043, Germany.
概括
氨酸通过与BDCA-2结合来抑制血类树突细胞 (pDC) 激活,从而减少I型干扰素的产生. 一种可溶的BDCA-2形式起到对抗作用,增加干扰素的产生,其水平在某些疾病中发生变化.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 等离子体树突细胞 (pDCs) 对于天生的免疫是至关重要的,在通过托尔类受体 (TLRs) 感知病原体相关的分子模式时产生I型干扰素 (IFN).
- 异常的pDC激活和过度的I型IFN产生与各种自身免疫性疾病的发病有关.
- 了解控制pDC激活的调控机制对于开发针对这些疾病的向疗法至关重要.
研究的目的:
- 研究肝素与pDC特异性受体BDCA-2之间的相互作用.
- 阐明这种相互作用在pDCs调节TLR9介导的I型IFN产生中的作用.
- 确定BDCA-2的可溶性形式,并评估它们对pDC功能和疾病相关性的影响.
主要方法:
- 生物化学试验用于研究肝素与BDCA-2和相关讲蛋白的结合.
- 使用初级人类pDC和CAL-1细胞系来测量I型IFN生产的功能测试.
- 从健康个人和感染性或自身免疫性疾病患者的血中量化可溶性BDCA-2 (solBDCA-2) 水平.
主要成果:
- 氨酸特别结合人类的BDCA-2,抑制TLR9驱动的pDCs中的I型IFN产生.
- 这种抑制依赖于氨酸硫化和BDCA-2糖化,并由外源和内源氨酸介导.
- 确定了一种依赖激活的BDCA-2 (solBDCA-2) 溶解形式,作为肝素抗剂,增强TLR9驱动的IFN-α产生. solBDCA-2的水平在型风患者中升高,与抗dsDNA抗体相关,而在型皮虫和牛皮患者中降低.
结论:
- 一个涉及肝素,膜结合的BDCA-2和solBDCA-2的新型调节网络调节了pDC中的TLR9驱动的IFN-α产生.
- 这些发现揭示了当地的血液环境影响pDC反应的机制.
- 这项研究提供了对pDC调节的见解,对I型IFN相关的自身免疫性疾病具有潜在的治疗意义.
更多相关视频
相关概念视频
Immune Response Against Viral Pathogens
780
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
780
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K


